Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine Fumarate IR for Agitation and Aggression in Acute Schizophrenia
NCT00838032Phase 4Unknown
- Sponsor
- Sichuan University
- Start
- Aug 2008
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine (extended-release tablet, brand name: Bipresso) in schizophrenia, sponsored by Sichuan University. Status: unknown.
02
Drugs
quetiapine (extended-release tablet, brand name: Bipresso)
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00838032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00838032.